Skip navigation
Watchlist Sponsored By :


Current DateTime: 09:12:50 12 Nov 2009
LinksList Documentid: 24355697

FEATURED QUIZZES


Current DateTime: 09:12:50 12 Nov 2009
LinksList Documentid: 33793611
  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?

  • The Many Myths of Coca-Cola

      Can you tell which statements are true, and which ones are just rumors?

  • Think You Understand Markets?

      We've selected some questions from the Financial Industry Regulatory Authority's test of investor knowledge. See how you do ...


Current DateTime: 09:12:50 12 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
CV Therapeutics Angina Drug Not Effective in Study; Shares Plunge
By: CNBC.com | 07 Mar 2007 | 11:26 AM ET
Text Size

Shares of CV Therapeutics plummeted [CVTX  Loading...      ()   ] following the company's announcement late Tuesday that its angina drug ranolazine was not effective in a study of acute and long-term treatment of patients with a type of heart disease known as acute coronary syndrome.

Wednesday's drop came on top of the shares losing more than a quarter of their value in after-market trading Tuesday.

There was no adverse trend in death or arrhythmias in patients taking the drug, also known by the chemical name ranolazine, the company said.

CV Therapeutics said it believes the data could support expansion of the drug's approved uses to be included as a first choice treatment for angina. It is currently approved to treat chronic angina in patients who have not achieved an adequate response with other drugs.

© 2009 CNBC.com
Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • Billboard allows music lovers to watch concerts for free online, with five different camera angles.
  • US real estate prices have fallen dramatically, but some places are still doing well. See the best-performing zip codes this year.
  • Vote and suggest your own, and remember--there's a fine line between a hero and a zero.
  • A European dating site finds lovelorn singles from one specific country to be uglier than any other. Who is it?
  • Contributor David Pogue looks at two of the latest efforts to perfect the digital pocket camera.
  • Just in time for the holidays, the Triumph company of Japan offers the latest innovation in women’s undergarments.
ADD COMMENTS
Remaining characters


Current DateTime: 06:21:11 12 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 08:53:44 12 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:04:03 12 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:01:49 12 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters